EVALUATING THE SAFETY OF TUMOR TREATING FIELDS (TTFIELDS) APPLICATION TO THE TORSO - IN VIVO STUDIES

被引：0
|
作者：
Davidi, Shiri [1 ]
Blat, Roni [1 ]
Munster, Mijal [1 ]
Shteingauz, Anna [1 ]
Cahal, Shay [1 ]
Giladi, Moshe [1 ]
Weinberg, Uri [1 ]
Palti, Yoram [1 ]
Giladi, Moshe [1 ]
机构：
[1] Novocure, Haifa, Israel
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-SITC2020.0176
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
176
引用
收藏
页码：A105 / A105
页数：1
相关论文
共 50 条
  • [21] ALTERATION OF BLOOD BRAIN BARRIER (BBB) PERMEABILITY BY TUMOR TREATING FIELDS (TTFIELDS) IN VIVO
    Kessler, A. F.
    Salvador, E.
    Domroese, D.
    Burek, M.
    Brami, C. Tempel
    Sela, T. Voloshin
    Giladi, M.
    Ernestus, R.
    Loehr, M.
    Foerster, C.
    Hagemann, C.
    NEURO-ONCOLOGY, 2019, 21 : 49 - 49
  • [22] THE INOVIVO SYSTEM: A NOVEL PRECLINICAL TOOL FOR IN VIVO DELIVERY OF TUMOR TREATING FIELDS (TTFIELDS)
    Davidi, Shiri
    Blat, Roni
    Shteingauz, Anna
    Porat, Yaara
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    NEURO-ONCOLOGY, 2020, 22 : 104 - 104
  • [23] Tumor treating fields (TTFields) in combination with sorafenib inhibit hepatocellular carcinoma in vitro and in vivo
    Potter, Wyatt
    Davidi, Shiri
    Jacobovitch, Sara
    Shteingauz, Anna
    Tempel-Brami, Catherine
    Zeevi, Einav
    Dor-On, Eyal
    Schneiderman, Rosa S.
    Voloshin, Tali
    Tzchori, Itai
    Haber, Adi
    Giladi, Moshe
    Kinzel, Adrian
    Weinberg, Uri
    Palti, Yoram
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [24] THE BLOOD BRAIN BARRIER (BBB) PERMEABILITY IS ALTERED BY TUMOR TREATING FIELDS (TTFIELDS) IN VIVO
    Schulz, Ellina
    Kessler, Almuth F.
    Salvador, Ellaine
    Domrose, Dominik
    Burek, Malgorzata
    Brami, Catherine Tempel
    Sela, Tali Voloshin
    Giladi, Moshe
    Ernestus, Ralf-Ingo
    Lohr, Mario
    Forster, Carola
    Hagemann, Carsten
    NEURO-ONCOLOGY, 2019, 21 : 82 - 82
  • [25] The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts
    Nancy Ann Oberheim-Bush
    Wenyin Shi
    Michael W. McDermott
    Alexander Grote
    Julia Stindl
    Leonardo Lustgarten
    Journal of Neuro-Oncology, 2022, 158 : 453 - 461
  • [26] CLINICAL EXPERIENCE WITH TUMOR TREATING FIELDS (TTFIELDS, OPTUNE®) IN ISRAEL - PATIENT ACCEPTANCE AND SAFETY
    Siegal, Tali
    Bokstein, Felix
    Blumenthal, Deborah T.
    Zach, Leor
    Leibovici, Anca
    Yust-Katz, Shlomit
    Lossos, Alexander
    Tzuk-Shina, Tzahala
    Lokiec, Alejandro
    Grossman, Rachel
    Forschner, Itay
    Taliansky, Alisa
    Ram, Zvi
    NEURO-ONCOLOGY, 2018, 20 : 119 - 119
  • [27] FIRST SAFETY ANALYSIS OF ANAPLASTIC MENINGIOMA PATIENTS TREATED WITH TUMOR TREATING FIELDS (TTFIELDS)
    Mawrin, Christian
    NEURO-ONCOLOGY, 2020, 22 : 56 - 56
  • [28] The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts
    Oberheim-Bush, Nancy Ann
    Shi, Wenyin
    McDermott, Michael W.
    Grote, Alexander
    Stindl, Julia
    Lustgarten, Leonardo
    JOURNAL OF NEURO-ONCOLOGY, 2022, 158 (03) : 453 - 461
  • [29] Tumor Treating Fields (TTFields) Application Promotes a Pro-inflammatory Phenotype in Macrophages
    Barsheshet, Y.
    Brant, B.
    Voloshin, T.
    Volodin, A.
    Koren, L.
    Koltun, B.
    Klein-Goldberg, A.
    Zemer-Tov, E.
    Kan, T.
    Paz, R.
    Giladi, M.
    Weinberg, U.
    Palti, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S561 - S562
  • [30] INCREASED CANCER CELL PERMEABILITY FOLLOWING TUMOR TREATING FIELDS (TTFIELDS) APPLICATION IN VITRO
    Voloshin, Tali
    Porat, Yaara
    Kaynan, Noa
    Klein-Goldberg, Anat
    Paz, Rom
    Volodin, Alexandra
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    NEURO-ONCOLOGY, 2020, 22 : 102 - 102
12345